Verma Archit, Yu Changhua, Bachl Stefanie, Lopez Ivan, Schwartz Morgan, Moen Erick, Kale Nupura, Ching Carter, Miller Geneva, Dougherty Tom, Pao Ed, Graf William, Ward Carl, Jena Siddhartha, Marson Alex, Carnevale Julia, Van Valen David, Engelhardt Barbara E
Institute of Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA, USA.
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
bioRxiv. 2024 Nov 21:2024.11.19.624390. doi: 10.1101/2024.11.19.624390.
T cell therapies, such as chimeric antigen receptor (CAR) T cells and T cell receptor (TCR) T cells, are a growing class of anti-cancer treatments. However, expansion to novel indications and beyond last-line treatment requires engineering cells' dynamic population behaviors. Here we develop the tools for of T cells from live-cell imaging, a common and inexpensive experimental setup used to evaluate engineered T cells. We first develop a state-of-the-art segmentation and tracking pipeline, , based on human-in-the-loop deep learning. We then build the pipeline to collect a catalog of phenotypes that characterize cell populations, morphology, movement, and interactions in co-cultures of modified T cells and antigen-presenting tumor cells. We use Caliban and Occident to interrogate how interactions between T cells and cancer cells differ when beneficial knock-outs of and are introduced into TCR T cells. We apply spatiotemporal models to quantify T cell recruitment and proliferation after interactions with cancer cells. We discover that, compared to a safe harbor knockout control, knockout T cells have longer interaction times with cancer cells leading to greater T cell activation and killing efficacy, while knockout T cells have increased proliferation rates leading to greater numbers of T cells for hunting. Together, segmentation and tracking from Caliban and phenotype quantification from Occident enable cellular behavior analysis to better engineer T cell therapies for improved cancer treatment.
嵌合抗原受体(CAR)T细胞和T细胞受体(TCR)T细胞等T细胞疗法是一类不断发展的抗癌治疗方法。然而,要扩展到新的适应症以及超越一线治疗,就需要对细胞的动态群体行为进行工程改造。在这里,我们利用活细胞成像技术开发了用于T细胞分析的工具,活细胞成像是一种常用且成本低廉的实验设置,用于评估工程化T细胞。我们首先基于人工参与的深度学习开发了一种先进的分割和跟踪流程。然后,我们构建了表型分析流程,以收集一系列表型,这些表型可表征修饰的T细胞与抗原呈递肿瘤细胞共培养中的细胞群体、形态、运动和相互作用。我们使用Caliban和Occident来探究当将特定基因的有益敲除引入TCR T细胞时,T细胞与癌细胞之间的相互作用有何不同。我们应用时空模型来量化T细胞与癌细胞相互作用后的募集和增殖情况。我们发现,与安全港敲除对照相比,特定基因敲除的T细胞与癌细胞的相互作用时间更长,从而导致更大的T细胞活化和杀伤功效,而另一种特定基因敲除的T细胞增殖率增加,从而产生更多用于杀伤的T细胞。总之,Caliban的分割和跟踪以及Occident的表型量化能够进行细胞行为分析,从而更好地设计T细胞疗法以改善癌症治疗效果。